Open field behaviour in rats: Role of metabotropic glutamate receptors

NeuroReport

Volumn 6, Issue 17, 1995, Pages 2389-2393

  Wetzel, Wolfram ^a   Wagner, Thomas ^a   Reymann, Klaus G ^b   Riedel, Gemot ^b,c  

^a Laboratory of Neuropharmacology ^*  (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

L.c.v. injection; MCPG; Metabotropic glutamate receptors (mGluRs); Open field behaviour; Rats; tADA

Indexed keywords

ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; AZETIDINE 2,4 DICARBOXYLIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ANIMALS; AZETIDINECARBOXYLIC ACID; BEHAVIOR, ANIMAL; BENZOATES; CYCLIC AMP; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; PHOSPHOLIPASE C; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SPACE PERCEPTION;

EID: 0029585415     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/00001756-199511270-00027     Document Type: Article

References (25)

1. O'Keefe J and Nadel L. The hippocampus as a cognitive map, Oxford University Press, 1978.
2. Bliss TVP and Lomo T. J Physiol (London) 232, 331-356 (1973).
3. Morris RGM, Andersen E, Lynch G et al. Nature 319, 774-776 (1986).
4. Riedel G, Wetzel W and Reymann KG. Neurosci Lett 167, U1-144 (1994).
5. Riedel G, Casabona G and Reymann KG. J Neurosci 15, 87-98 (1995).
6. Richter-Levin G, Errington ML, Maegawa H etal. Neuropharmacol 33 853-857 (1994).
7. Bianchin M, Dasilva RC, Schmitz PK etal. BehavPharmacol 5, 356-359 (1994).
8. Pettit HO, Lutz D, Gutierrez C et al. Neurosci Lett 178, 43-46 (1994).
9. Kaba H, Hayashi Y, Higuchi T ef al. Science 265, 262-264 (1994).
10. Denenberg VH. Ann NY Acad Sci 159, 852-859 (1969).
11. Walsh RN and Cummings RA. Psychol Bull 83, 482-504 (1976).
12. Platel A and Porsolt RD. Psychopharmacoll 78. 346-352 (1982).
13. Pin JP and Duvoisin R. Neuropharmacol 34, 1-26 (1995).
14. Favaron M, Manev RM, Candeo P etal. NeuroReport 4, 967-970 (1993).
15. Riedel G, Manahan-Vaughan D, Kozikowski AP ef al. Neuropharmacol 34, 1107-1109(1995).
16. Peeke HVS and Veno A. Behav Biol 8, 427-432 (1973).
17. Riedel G, Wetzel W, Vieweg S etal. Soc NeurosciAbstr 20, 1018 (1994).
18. Wetzel W and Riedel G. Eur J Neurosci Suppl 7114, (1994).
19. Riedel G, Wetzel W, Kozikowski AP etal. Neuropharmacol 34, 559-561 (1995).
20. Riedel G, Wetzel W, Vieweg S et al. On the relationship between long-term potentiation and learning in vivo: II. Injections of metabotropic glutamate receptor agonist tADA. In: Eisner N, Menzel R, eds. Learning and Memory, Thieme Verlag, Stuttgart 1995: 115.
21. Jiltunen AJ and Jaerbe TUC. Psychopharmacol 102, 207-212 (1990).
22. Glickman SE, Higgins TJ and Isaacson RL. Physiol Behav 5, 931-938 (1970).
23. Conquet F, Bashir Zl, Davias CH etal. Nature 372, 237-243 (1994).
24. Hughes RN, Blampied MN and Stewart WJ. Pharmacol Biochem Behav 3, 731-734 (1975).
25. Van Abeelen JHF, Ellenbrock GA and Wigman HGAJ. Psychopharmacol 41, 111-112 (1975).